PRNewsWire · CADL · November 19, 2026
Candel Therapeutics (CADL) Faces Investor Scrutiny After Surprise BLA Delay Drives Stock 26% Lower - Hagens Berman

Get the app for more
Explore stock news, insights and company research.
Get the app → Source: PRNewsWire ↗